Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 29, 2026
YIA26-003: Characterizing the Peripheral T-Cell Repertoire in Patients With Unresectable Melanoma Treated With the IDO- and PD-L1 Targeted Peptide Vaccine IO102-IO103 and Nivolumab-Relatlimab Fixed-Dose Combination.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 13, 2024
A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
Journal: Cancer
Published: August 24, 2020
Amyloid Deposition of the Bilateral Ureters in a Patient With Chronic Systemic AL Amyloidosis.
Journal: Urology
Published: March 31, 2020
Antiphospholipid Syndrome Presenting With Splenic Infarct.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: November 26, 2019
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 01, 2019
MEK targeting in N-RAS mutated metastatic melanoma.
Journal: Molecular cancer
Published: November 16, 2013
Drug targets and predictive biomarkers in the management of metastatic melanoma.
Journal: Pharmacogenomics and personalized medicine
Published: September 27, 2012
FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity.
Journal: Medical oncology (Northwood, London, England)
Published: August 29, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026